Search

everythinglearnresearchcommunity

for

Search:↓

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

PLD is an effective and safer alternative for treating breast cancer.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The drug combination was safe and showed promise in treating advanced tumors.

The combination treatment showed a higher response rate but no significant survival benefits.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.